86 related articles for article (PubMed ID: 16199090)
1. Cloning and molecular characterization of a human recombinant IgG Fab binding to the Tat protein of human immunodeficiency virus type 1 (HIV-1) derived from the repertoire of a seronegative patient.
Mancini N; Perotti M; Carletti S; Canducci F; Sampaolo M; Clementi M; Burioni R
Mol Immunol; 2006 Mar; 43(9):1363-9. PubMed ID: 16199090
[TBL] [Abstract][Full Text] [Related]
2. Determinants of polyreactivity in a large panel of recombinant human antibodies from HIV-1 infection.
Ditzel HJ; Itoh K; Burton DR
J Immunol; 1996 Jul; 157(2):739-49. PubMed ID: 8752924
[TBL] [Abstract][Full Text] [Related]
3. N-terminal mutations in the anti-estradiol Fab 57-2 modify its hapten binding properties.
Saviranta PJauria P; Lamminmäki U; Hellman J; Eriksson S; Lövgren T
Protein Sci; 2000 Dec; 9(12):2547-56. PubMed ID: 11206076
[TBL] [Abstract][Full Text] [Related]
4. Restricted VH3 gene usage in phage-displayed Fab that are selected by intravenous immunoglobulin.
Osei A; Uttenreuther-Fischer MM; Lerch H; Gaedicke G; Fischer P
Arthritis Rheum; 2000 Dec; 43(12):2722-32. PubMed ID: 11145030
[TBL] [Abstract][Full Text] [Related]
5. Tumor cell retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-derived peptide.
Anderson DC; Nichols E; Manger R; Woodle D; Barry M; Fritzberg AR
Biochem Biophys Res Commun; 1993 Jul; 194(2):876-84. PubMed ID: 8343170
[TBL] [Abstract][Full Text] [Related]
6. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
[TBL] [Abstract][Full Text] [Related]
7. Interactions of the HIV-1 Tat and RAP74 proteins with the RNA polymerase II CTD phosphatase FCP1.
Abbott KL; Archambault J; Xiao H; Nguyen BD; Roeder RG; Greenblatt J; Omichinski JG; Legault P
Biochemistry; 2005 Mar; 44(8):2716-31. PubMed ID: 15723517
[TBL] [Abstract][Full Text] [Related]
8. [Cloning of human monoclonal Fab fragments against HIV-1 gp120 peptide binding chemokine receptor from phage Fab antibody library].
Shen H; Mao P; Hong S; Hou J; Yang J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):357-60. PubMed ID: 12665905
[TBL] [Abstract][Full Text] [Related]
9. Conversion of a mouse Fab into a whole humanized IgG antibody for detecting botulinum toxin.
Palys TJ; Schmid KE; Scherer JM; Schoepp RJ
Hum Antibodies; 2006; 15(4):125-32. PubMed ID: 17522434
[TBL] [Abstract][Full Text] [Related]
10. Targeting of HIV-1 Tat traffic and function by transduction-competent single chain antibodies.
Theisen DM; Pongratz C; Wiegmann K; Rivero F; Krut O; Krönke M
Vaccine; 2006 Apr; 24(16):3127-36. PubMed ID: 16497417
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human Fab antibody fragments to HIV-1 Rev and Tat regulatory proteins: direct selection from a combinatorial phage display library.
Pilkington GR; Duan L; Zhu M; Keil W; Pomerantz RJ
Mol Immunol; 1996; 33(4-5):439-50. PubMed ID: 8676895
[TBL] [Abstract][Full Text] [Related]
12. [Generation of human recombinant antibody Fab fragment and its IgG to adeno-associated virus type II from phage display library].
Yao LS; Wang T; Liang MF; Yuan ZH; Ji Y; Wu XB; Li DX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):240-3. PubMed ID: 15340567
[TBL] [Abstract][Full Text] [Related]
13. The Sp1 transcription factor does not directly interact with the HIV-1 Tat protein.
Loregian A; Bortolozzo K; Boso S; Sapino B; Betti M; Biasolo MA; Caputo A; Palú G
J Cell Physiol; 2003 Aug; 196(2):251-7. PubMed ID: 12811817
[TBL] [Abstract][Full Text] [Related]
14. Construction and characterization of a Fab recombinant protein for Japanese encephalitis virus neutralization.
Wu SC; Lin YJ; Chou JW; Lin CW
Vaccine; 2004 Nov; 23(2):163-71. PubMed ID: 15531033
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Tat-specific IgG antibodies in high-responders target a B-cell epitope in the cysteine-rich domain and block extracellular Tat efficiently.
Kashi VP; Jacob RA; Paul S; Nayak K; Satish B; Swaminathan S; Satish KS; Ranga U
Vaccine; 2009 Nov; 27(48):6739-47. PubMed ID: 19744585
[TBL] [Abstract][Full Text] [Related]
16. Delivery of the HIV-1 Tat protein to dendritic cells by the CyaA vector induces specific Th1 responses and high affinity neutralizing antibodies in non human primates.
Mascarell L; Bauche C; Fayolle C; Diop OM; Dupuy M; Nougarede N; Perraut R; Ladant D; Leclerc C
Vaccine; 2006 Apr; 24(17):3490-9. PubMed ID: 16524647
[TBL] [Abstract][Full Text] [Related]
17. Two-phase approach for the expression of high-affinity human anti-human immunodeficiency virus immunoglobulin Fab domains in Escherichia coli.
Takeda S; Dorfman NA; Robert-Guroff M; Notkins AL; Rando RF
Hybridoma; 1995 Feb; 14(1):9-18. PubMed ID: 7768538
[TBL] [Abstract][Full Text] [Related]
18. Cloning and expression in E. coli of a functional Fab fragment obtained from single human lymphocyte against anthrax toxin.
Masri SA; Rast H; Hu WG; Nagata LP; Chau D; Jager S; Mah D
Mol Immunol; 2007 Mar; 44(8):2101-6. PubMed ID: 17045651
[TBL] [Abstract][Full Text] [Related]
19. A synthetic HIV-1 Tat protein breaches the skin barrier and elicits Tat-neutralizing antibodies and cellular immunity.
Partidos CD; Moreau E; Chaloin O; Tunis M; Briand JP; Desgranges C; Muller S
Eur J Immunol; 2004 Dec; 34(12):3723-31. PubMed ID: 15549730
[TBL] [Abstract][Full Text] [Related]
20. [Construction of phage antibody library with predetermined CDR3 gene and screening of humanized Fab of anti-human integrin alphanubeta3 monoclonal antibody].
Wang C; Hou LH; Du GX; Li JM; Chen PY; Tong YG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):64-7. PubMed ID: 17210111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
